Making the Switch: Why Reversal is Replacing Management for Diabetes and Weight Loss
Find out why leaders are saying goodbye to management programs that lack outcomes and ROI, and making the switch to reversal for diabetes and obesity.
Rethinking Obesity Strategies Amid the Rise of GLP-1 Drugs and Lifestyle Programs for Weight Loss
Whether your organization has felt the tidal wave of GLP-1 claims yet or not - it's coming. Learn about a new set of options to navigate this spike.
GLP-1s and Health Equity: Are rising utilization and Rx prices widening health disparities? [Webinar Replay]
GLP-1 drugs are hitting the market with new indications but are rising utilization and prices widening health disparities?
Why AutoZone Made the Switch from Management to Reversal for Diabetes & Weight Loss [Webinar Replay]
Find out why leading orgs, like AutoZone, are putting a bullseye on underperforming management programs and upgrading to reversal.
How Health Plan Leaders Are Handling the GLP-1 Cost Crisis [Survey Report]
A new survey of 80 Chief Medical Officers, Chief Pharmacy Officers and actuarial leaders shines a light on the growing GLP-1 cost crisis
Closing Health Equity Gaps: Making Equitable Diabetes Care a Reality [Webinar Replay]
Digital healthcare has long touted a promise to address health disparities, but is the new wave of solutions making any headway in closing health equity gaps in type 2 diabetes? Research says yes.
AutoZoners eliminate half of diabetes medications at one year with Virta
Amid rising rates of cardiovascular disease, diabetes and related comorbid conditions, AutoZone turned to Virta to help get costs under control and improve the quality of life of their AutoZoners.
State of the Union: Health Disparities in Employer-sponsored Insurance [Webinar Replay]
More than 150 million Americans depend on employer-sponsored insurance (ESI) for their health care, but the health outcomes of ESI enrollees has not been well understood given historical data gaps and limitations in analyzing health outcomes across race, ethnicity and income.
AutoZone is Reversing Prediabetes, Obesity, and Type 2 Diabetes with Virta Health
AutoZone Vice President, Matt Harmon, talks about partnering with Virta to reverse prediabetes, obesity and type 2 diabetes for his employees.
The Iron Triangle of Digital Health: Validation, ROI, Sustainability [Webinar Replay]
Clinical validation, ROI and sustainability - is it possible to have all three? Learn how to separate fact from fiction and identify vendors delivering best-in-class outcomes.
Diabetes Reversal: Benefits Beyond Metabolic Health [Webinar Replay]
How we treat diabetes is changing. Reversal - not management - is the new gold standard. Learn about the benefits of diabetes reversal, beyond metabolic health.
Obesity, Prediabetes & Diabetes: How Employers Are Addressing the Full Spectrum of Metabolic Health [Webinar Replay]
With 50% of adults suffering from chronic metabolic health problems like uncontrolled blood sugar and obesity, poor metabolic health is one of the costliest and riskiest threats to population health in the U.S.